Licensing and Collaborative Opportunities

Senexis is actively seeking to enter into collaborations and licensing deals with established pharmaceutical and emerging biotechnology companies.

Out-licensing

Senexis plans to offer a balanced portfolio of pre-clinical or early clinical licensing opportunities to the pharmaceutical sector, particularly in the more costly areas of clinical development.

For further information outside Japan, please contact Mark Treherne.

For Japan, please contact Dr Jun Ishiguro.